Figures & data
Table 1. Characteristics of the study patients and admissions for the total sample and by IV fluid administered.
Figure 2. Overall survival curves for sepsis patients treated with Albumin and Crystalloids over 90-day horizon.
![Figure 2. Overall survival curves for sepsis patients treated with Albumin and Crystalloids over 90-day horizon.](/cms/asset/38dfa5df-0044-48e9-8bea-ec7f745f16b1/ijme_a_2296196_f0002_c.jpg)
Table 2. The results of the cost-effectiveness analysis.
Supplemental Material
Download MS Word (95 KB)Data availability statement
The data underlying this article will be shared upon reasonable request to the corresponding author.